Savior Lifetec Corporation (TPEX:4167)
17.10
+0.10 (0.59%)
Oct 31, 2025, 1:30 PM CST
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 5.43 billion as of October 31, 2025. Its market cap has decreased by -19.72% in one year.
Market Cap
5.43B
Enterprise Value
3.88B
Revenue
1.21B
Ranking
n/a
PE Ratio
11.82
Stock Price
17.10
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 5.43B, an increase of 44.73%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.43B | -16.18% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | 10.34B | 75.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |